Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 85614-52-4 | MDL No. : | MFCD19665411 |
Formula : | C7H11NO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YLLVYVFTLNSJMR-UHFFFAOYSA-N |
M.W : | 173.17 | Pubchem ID : | 44154173 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.71 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 43.11 |
TPSA : | 66.84 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -8.26 cm/s |
Log Po/w (iLOGP) : | 1.42 |
Log Po/w (XLOGP3) : | -1.27 |
Log Po/w (WLOGP) : | -1.63 |
Log Po/w (MLOGP) : | -1.03 |
Log Po/w (SILICOS-IT) : | -0.37 |
Consensus Log Po/w : | -0.58 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | 0.08 |
Solubility : | 210.0 mg/ml ; 1.21 mol/l |
Class : | Highly soluble |
Log S (Ali) : | 0.36 |
Solubility : | 399.0 mg/ml ; 2.31 mol/l |
Class : | Highly soluble |
Log S (SILICOS-IT) : | 0.11 |
Solubility : | 225.0 mg/ml ; 1.3 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.09 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 62613-81-4 ]
Ethyl 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetate
Similarity: 0.96
[ 77191-37-8 ]
2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetic acid
Similarity: 0.89
[ 99437-11-3 ]
(S)-2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetic acid
Similarity: 0.89
[ 222856-39-5 ]
4-Hydroxy-1-methylpyrrolidin-2-one
Similarity: 0.79
[ 120428-80-0 ]
N-(2-Amino-2-oxoethyl)-2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide
Similarity: 0.78
[ 62613-81-4 ]
Ethyl 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetate
Similarity: 0.96
[ 77191-37-8 ]
2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetic acid
Similarity: 0.89
[ 59776-88-4 ]
Methyl 2-(2-oxopyrrolidin-1-yl)acetate
Similarity: 0.89
[ 99437-11-3 ]
(S)-2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetic acid
Similarity: 0.89
[ 497250-66-5 ]
tert-Butyl 2-(2-oxopyrrolidin-1-yl)acetate
Similarity: 0.83
[ 62613-81-4 ]
Ethyl 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetate
Similarity: 0.96
[ 59776-88-4 ]
Methyl 2-(2-oxopyrrolidin-1-yl)acetate
Similarity: 0.89
[ 497250-66-5 ]
tert-Butyl 2-(2-oxopyrrolidin-1-yl)acetate
Similarity: 0.83
[ 61516-76-5 ]
Ethyl 2-(2-oxoazepan-1-yl)acetate
Similarity: 0.82
[ 120125-66-8 ]
1-(Cyanomethyl)-5-Oxopyrrolidin-3-Yl Acetate
Similarity: 0.80
[ 62613-81-4 ]
Ethyl 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetate
Similarity: 0.96
[ 77191-37-8 ]
2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetic acid
Similarity: 0.89
[ 59776-88-4 ]
Methyl 2-(2-oxopyrrolidin-1-yl)acetate
Similarity: 0.89
[ 99437-11-3 ]
(S)-2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetic acid
Similarity: 0.89
[ 497250-66-5 ]
tert-Butyl 2-(2-oxopyrrolidin-1-yl)acetate
Similarity: 0.83